Selected research
Industry Research
Antibiotics and Antimycotics Industry Research Report 2026
Market perspective
The global Antibiotics and Antimycotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antibiotics and Antimycotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antibiotics and Antimycotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antibiotics and Antimycotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antibiotics and Antimycotics include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Pfizer, GSK, Bayer and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antibiotics and Antimycotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antibiotics and Antimycotics Market by Company
Sanofi
Johnson & Johnson
Novartis
Merck
Roche
Pfizer
GSK
Bayer
AbbVie
AstraZeneca
Eli Lilly
Antibiotics and Antimycotics Segment by Type
Aminoglycosides
Macrolides
Sulfonamides
Quinolones (Fluoroquinolones)
Penicillins
Tetracyclines
Carbapenems
Cephalosporins
Other
Antibiotics and Antimycotics Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Antibiotics and Antimycotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics and Antimycotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and Antimycotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics and Antimycotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antibiotics and Antimycotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antibiotics and Antimycotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antibiotics and Antimycotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aminoglycosides
- Macrolides
- Sulfonamides
- Quinolones (Fluoroquinolones)
- Penicillins
- Tetracyclines
- Carbapenems
- Cephalosporins
- Other
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- Roche
- Pfizer
- GSK
- Bayer
- AbbVie
- AstraZeneca
- Eli Lilly
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antibiotics and Antimycotics Market Size (2021-2032)
- 2.2.2 Global Antibiotics and Antimycotics Sales (2021-2032)
- 2.2.3 Global Antibiotics and Antimycotics Market Average Price (2021-2032)
- 2.3 Antibiotics and Antimycotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aminoglycosides
- 2.3.3 Macrolides
- 2.3.4 Sulfonamides
- 2.3.5 Quinolones (Fluoroquinolones)
- 2.3.6 Penicillins
- 2.3.7 Tetracyclines
- 2.3.8 Carbapenems
- 2.3.9 Cephalosporins
- 2.3.10 Other
- 2.4 Antibiotics and Antimycotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antibiotics and Antimycotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antibiotics and Antimycotics Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Antibiotics and Antimycotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Antibiotics and Antimycotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Antibiotics and Antimycotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antibiotics and Antimycotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antibiotics and Antimycotics, Product Type & Application
- 3.8 Global Manufacturers of Antibiotics and Antimycotics, Established Date
- 3.9 Global Antibiotics and Antimycotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Antibiotics and Antimycotics Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Antibiotics and Antimycotics Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Antibiotics and Antimycotics Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Antibiotics and Antimycotics Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Roche
- 4.5.1 Roche Company Information
- 4.5.2 Roche Business Overview
- 4.5.3 Roche Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Roche Antibiotics and Antimycotics Product Portfolio
- 4.5.5 Roche Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Antibiotics and Antimycotics Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Antibiotics and Antimycotics Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Antibiotics and Antimycotics Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 AbbVie
- 4.9.1 AbbVie Company Information
- 4.9.2 AbbVie Business Overview
- 4.9.3 AbbVie Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AbbVie Antibiotics and Antimycotics Product Portfolio
- 4.9.5 AbbVie Recent Developments
- 4.10 AstraZeneca
- 4.10.1 AstraZeneca Company Information
- 4.10.2 AstraZeneca Business Overview
- 4.10.3 AstraZeneca Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AstraZeneca Antibiotics and Antimycotics Product Portfolio
- 4.10.5 AstraZeneca Recent Developments
- 4.11 Eli Lilly
- 4.11.1 Eli Lilly Company Information
- 4.11.2 Eli Lilly Business Overview
- 4.11.3 Eli Lilly Antibiotics and Antimycotics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Eli Lilly Antibiotics and Antimycotics Product Portfolio
- 4.11.5 Eli Lilly Recent Developments
5 Global Antibiotics and Antimycotics Market Scenario by Region
- 5.1 Global Antibiotics and Antimycotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antibiotics and Antimycotics Sales by Region: 2021-2032
- 5.2.1 Global Antibiotics and Antimycotics Sales by Region: 2021-2026
- 5.2.2 Global Antibiotics and Antimycotics Sales by Region: 2027-2032
- 5.3 Global Antibiotics and Antimycotics Revenue by Region: 2021-2032
- 5.3.1 Global Antibiotics and Antimycotics Revenue by Region: 2021-2026
- 5.3.2 Global Antibiotics and Antimycotics Revenue by Region: 2027-2032
- 5.4 North America Antibiotics and Antimycotics Market Facts & Figures by Country
- 5.4.1 North America Antibiotics and Antimycotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antibiotics and Antimycotics Sales by Country (2021-2032)
- 5.4.3 North America Antibiotics and Antimycotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antibiotics and Antimycotics Market Facts & Figures by Country
- 5.5.1 Europe Antibiotics and Antimycotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antibiotics and Antimycotics Sales by Country (2021-2032)
- 5.5.3 Europe Antibiotics and Antimycotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antibiotics and Antimycotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antibiotics and Antimycotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antibiotics and Antimycotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antibiotics and Antimycotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antibiotics and Antimycotics Market Facts & Figures by Country
- 5.7.1 South America Antibiotics and Antimycotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antibiotics and Antimycotics Sales by Country (2021-2032)
- 5.7.3 South America Antibiotics and Antimycotics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Antibiotics and Antimycotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antibiotics and Antimycotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antibiotics and Antimycotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antibiotics and Antimycotics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antibiotics and Antimycotics Sales by Type (2021-2032)
- 6.1.1 Global Antibiotics and Antimycotics Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Antibiotics and Antimycotics Sales Market Share by Type (2021-2032)
- 6.2 Global Antibiotics and Antimycotics Revenue by Type (2021-2032)
- 6.2.1 Global Antibiotics and Antimycotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antibiotics and Antimycotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Antibiotics and Antimycotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antibiotics and Antimycotics Sales by Application (2021-2032)
- 7.1.1 Global Antibiotics and Antimycotics Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Antibiotics and Antimycotics Sales Market Share by Application (2021-2032)
- 7.2 Global Antibiotics and Antimycotics Revenue by Application (2021-2032)
- 7.2.1 Global Antibiotics and Antimycotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antibiotics and Antimycotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Antibiotics and Antimycotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antibiotics and Antimycotics Value Chain Analysis
- 8.1.1 Antibiotics and Antimycotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antibiotics and Antimycotics Production Mode & Process
- 8.2 Antibiotics and Antimycotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antibiotics and Antimycotics Distributors
- 8.2.3 Antibiotics and Antimycotics Customers
9 Global Antibiotics and Antimycotics Analyzing Market Dynamics
- 9.1 Antibiotics and Antimycotics Industry Trends
- 9.2 Antibiotics and Antimycotics Industry Drivers
- 9.3 Antibiotics and Antimycotics Industry Opportunities and Challenges
- 9.4 Antibiotics and Antimycotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst